Quiz 3 Flashcards
Produces a defined toxic effect in 50% of the individuals tested
MEC
MTC
Median Effective Dose
Median Toxic Dose
Median Toxic Dose
Produces the desired intensity of effect in 50% of the individuals tested
Median Effective Dose
MEC
Median Toxic Dose
MTC
Median Effective Dose
Area from ICH which includes - stability, light stability, analytical
validation, impurities & biotechnology
Safety topic
Quality topic
Regulatory topic
Efficacy topic
Quality Topic
Regularly schedule subsequent administration to keep the most desirable
concentration of drug in the blood
Loading dose
Therapeutic dose
Prophylactic dose
Maintenance dose
Maintenance dose
Factors in determining drug’s dose, EXCEPT:
Age
Concomitant drug therapy
Pathologic condition
Body weight
Room temperature
Room Temperature
Manufacturing scale-up activities
Phase IV
Determine drug tolerance and toxicity
Phase I
Subjects: Healthy volunteers (20100)
Phase I
Submission of NDA
Phase III
Subjects: Patients with disease (several hundreds-several thousands)
Phase III
Submission of IND
Preclinical Stage
Post Marketing Surveillance
Phase V
Animal Pharmacology and Toxicology data are obtained
Preclinical stage
Determines the therapeutic index
Phase II
Side effects are monitored
Phase III